GGrantIndex
Sort

89,613 grants matching depression

Deep Brain Stimulation of the Subgenual Cingulate Cortex for the Treatment of Medically Refractory Chronic Low Back Pain

$681,714
Ausaf A Bari · University Of California Los Angeles · UH3 · FY2019 · NS

Novel EtG BasedContingency Management for Alcohol in the Severely Mentally Ill

$681,714
Michael G McDonell · Washington State University · R01 · FY2017 · AA

Molecular Genetics Of Glutamate Function

$681,704
Robert H Lipsky · Alcohol Abuse And Alcoholism · Z01 · FY2007 · AA

The PRIORITY Study: from PRedIctiOn to pReventIon of youth-onset TYpe 2 diabetes

$681,677
Sheela Natesh Magge · Johns Hopkins University · U01 · FY2025 · DK

Enhanced Linkage of Drug Abusers to Primary Medical Care

$681,674
Jeffrey H Samet · Boston Medical Center · R01 · FY2009 · DA

Psychiatric and substance use disorders in Puerto Rico before and after Hurricane Maria

$681,661
Alexander N Ortega · Drexel University · R01 · FY2023 · MD

Development of a treatment for voiding dysfunction in spinal cord injured patients

$681,653
Lesley Marson · Dignify Therapeutics, Llc · R44 · FY2017 · HD

Anhedonia as a Risk Factor and Consequence of Substance Use

$681,647
Adam Matthew Leventhal · University Of Southern California · R01 · FY2015 · DA

Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress

$681,645
Stephen Ross · New York University School Of Medicine · R01 · FY2022 · CA

Genetic, Imaging, and Cognition study of Positive Valence Systems in Psychotic Syndromes

$681,629
Roel A Ophoff · University Of California Los Angeles · R01 · FY2018 · MH

Influence of Opioids on the Brainstem Respiratory Network

$681,623
Donald C Bolser · University Of Florida · R01 · FY2023 · HL

Influence of Opioids on the Brainstem Respiratory Network

$681,622
Donald C Bolser · University Of Florida · R01 · FY2022 · HL

Behavioral Pharmacology of Cannabinoid and Terpenoid Effects and Interactions

$681,612
Ryan G Vandrey · Johns Hopkins University · R01 · FY2018 · DA

Behavioral Pharmacology of Cannabinoid and Terpenoid Effects and Interactions

$681,611
Ryan G Vandrey · Johns Hopkins University · R01 · FY2020 · DA

A Hybrid Type 2 Trial of Trauma-Focused Cognitive Behavioral Therapy and a Pragmatic Individual-Level Implementation Strategy

$681,585
Aaron Robert Lyon · University Of Washington · R01 · FY2023 · MH

COVID-19 Policies: Impact Over Time on Child Health, Obesity, and Disparities

$681,578
Erin R Hager · Johns Hopkins University · R01 · FY2023 · HD

Determining the relationships between provider bias, experiences of ableism, and health outcomes for people with mobility disabilities

$681,469
Lynn A Worobey · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HD

Digital behavioral phenotyping and multi-region electrophysiology to determine behavioral and neural network changes underlying the stress response in mice

$681,455
Brendon O Watson · University Of Michigan At Ann Arbor · R01 · FY2021 · MH

Antidepressant Adherence via Telephonic Interactive Voice Recognition (IVR)

$681,440
Gregory N Clarke · Kaiser Foundation Research Institute · R01 · FY2010 · MH

Co-use of cannabis and prescription opioids in emerging adults in medical settings

$681,430
Anna Camille Wilson · Oregon Health & Science University · R01 · FY2024 · DA

Randomized Clinical Trial of a Novel Psychotherapy for Childhood Depression

$681,420
Maria Kovacs · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · MH

Biomarker Signatures for Delayed Cerebral Ischemia and Outcome Following Subarachnoid Hemorrhage

$681,385
Frank R Sharp · University Of California At Davis · R61 · FY2021 · NS

PSYCHOLOGIC/PHYSIOLOGIC HEALTH & METABOLIC STATUS IN AFRICAN AMERICANS

$681,379
Patricia A Deuster · Henry M. Jackson Fdn For The Adv Mil/Med · P20 · FY2008 · MD

The Neuroimmunology of Anhedonia

$681,368
Vilma Gabbay · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · MH

Psychiatric and Medical CoMorbidity in a Rural Community

$681,363
University Of North Carolina Chapel Hill · R01 · FY2003 · MH